Evaluation of Direct Oral Anticoagulation Therapy in Heart and Lung Transplant Recipients
Conclusion:
Direct oral anticoagulant therapy was well tolerated by thoracic transplant recipients. Drug interactions and renal dose adjustments were common.
Source: Progress in Transplantation - Category: Transplant Surgery Authors: Lichvar, A. B., Moore, C. A., Ensor, C. R., McDyer, J. F., Teuteberg, J. J., Shullo, M. A. Tags: Original Articles Source Type: research
More News: Bleeding | Cardiology | Coumadin | Heart | Heart Transplant | Lung Transplant | Study | Thrombosis | Transplant Surgery | Transplants | Warfarin